Talphera Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 15

Employees

  • Stock Symbol
  • TLPH

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.03
  • (As of Friday Closing)

Talphera General Information

Description

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Contact Information

Formerly Known As
AcelRx Pharmaceuticals, Inc., Surx, AcelRx Pharmaceuticals Inc, AcelRx Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 1850 Gateway Drive
  • Suite 175
  • San Mateo, CA 94404
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Talphera Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.03 $1.04 $0.42 - $1.61 $17.5M 17M 76.1K -$0.85

Talphera Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 8,097 (929) 15,391 48,343
Revenue 651 651 0 2,818
EBITDA (15,505) (16,578) 60,399 (33,992)
Net Income (14,199) (18,397) 47,755 (35,099)
Total Assets 28,772 20,395 47,487 77,893
Total Debt 2,780 0 5,363 18,621
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Talphera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Talphera‘s full profile, request access.

Request a free trial

Talphera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Talphera‘s full profile, request access.

Request a free trial

Talphera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medic
Pharmaceuticals
San Mateo, CA
15 As of 2023
00000
000000000 00000

000000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in re
000000000000000
Boston, MA
000 As of 0000
00000
000000000 00000

0000 0

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000 000000000
Bridgewater, NJ
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Talphera Competitors (85)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA 000 00000 000000000 00000
VYNE Therapeutics Formerly VC-backed Bridgewater, NJ 00 00000 000000000 00000
Orexigen Therapeutics Corporate Backed or Acquired San Diego, CA 000 00000 000000&0
AbbVie Corporation North Chicago, IL 00000 000.00 000000000 000.00
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
You’re viewing 5 of 85 competitors. Get the full list »

Talphera Executive Team (19)

Name Title Board Seat Contact Info
Vincent Angotti Chief Executive Officer & Board Member
Raffi Asadorian Chief Financial Officer
Shakil Aslam Chief Development Officer
Badri Dasu Chief Engineering Officer
Pamela Palmer Ph.D Chief Medical Officer & Founder
You’re viewing 5 of 19 executive team members. Get the full list »

Talphera Board Members (11)

Name Representing Role Since
Adrian Adams Self Chairman & Board Member 000 0000
Jill Broadfoot Self Board Member 000 0000
Mark Wan Three Arch Partners Board Member 000 0000
Stephen Hoffman Ph.D Skyline Ventures Board Member 000 0000
Vincent Angotti Talphera Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Talphera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Talphera Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lowell Therapeutics 10-Jan-2022 0000000000 000.00 Other Devices and Supplies
To view Talphera’s complete acquisitions history, request access »

Talphera ESG

Risk Overview

Risk Rating

Updated June, 13, 2021

44.61 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 14,042

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 947

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

00.00

Percentile

To view Talphera’s complete esg history, request access »

Talphera FAQs

  • When was Talphera founded?

    Talphera was founded in 2005.

  • Who is the founder of Talphera?

    Pamela Palmer Ph.D is the founder of Talphera.

  • Who is the CEO of Talphera?

    Vincent Angotti is the CEO of Talphera.

  • Where is Talphera headquartered?

    Talphera is headquartered in San Mateo, CA.

  • What is the size of Talphera?

    Talphera has 15 total employees.

  • What industry is Talphera in?

    Talphera’s primary industry is Pharmaceuticals.

  • Is Talphera a private or public company?

    Talphera is a Public company.

  • What is Talphera’s stock symbol?

    The ticker symbol for Talphera is TLPH.

  • What is the current stock price of Talphera?

    As of 24-May-2024 the stock price of Talphera is $1.03.

  • What is the current market cap of Talphera?

    The current market capitalization of Talphera is $17.5M.

  • What is Talphera’s current revenue?

    The trailing twelve month revenue for Talphera is $651K.

  • Who are Talphera’s competitors?

    Ironwood Pharmaceuticals, VYNE Therapeutics, Orexigen Therapeutics, AbbVie, and Merck & Co. are some of the 85 competitors of Talphera.

  • What is Talphera’s annual earnings per share (EPS)?

    Talphera’s EPS for 12 months was -$0.85.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »